|
Market Closed -
Euronext Paris
16:55:00 05/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.1900 EUR | 0.00% |
|
-17.18% | -99.78% |
| 06-30 | Neovacs bolsters its strategic intellectual property portfolio |  |
| 02-10 | Neovacs S.A. announced that it has received ?0.25 million in funding from Hanover Square Investments Pte Limted | CI |
Chart: Technical Analysis
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| ALNEV | Real-time | |
Deutsche Boerse AG
| 0LW1 | Delayed | |
|
Boerse Muenchen
| 0LW1 | Real-time | |
|
Börse Stuttgart
| 0LW1 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 0.259 | 0.68 | 4 |
| Spread/Res. | -26.64% | -72.06% | -95.25% |
| Spread/Supp. | +25.25% | +214.57% | +83.22% |
| Support | 0.1517 | 0.0604 | 0.1037 |
- Stock Market
- Stocks
- ALNEV Stock
- Charts NEOVACS
Select your edition
All financial news and data tailored to specific country editions
